ChemBriefAs Hims prepares for peptides launch, Wall Street cautious on prospects this year
Hims & Hers Health plans to launch legally available peptides in 2026, but analysts remain cautious about near-term revenue growth due to FDA regulatory uncertainties and limited differentiation from
reuters · 2026-08-12 11:32